122 related articles for article (PubMed ID: 9775124)
21. Leukotriene receptor antagonists and related compounds.
Wenzel SE
Can Respir J; 1999; 6(2):189-93. PubMed ID: 10322101
[TBL] [Abstract][Full Text] [Related]
22. Treatment of aspirin-intolerant asthma with antileukotrienes.
Dahlén B
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S137-41. PubMed ID: 10673243
[No Abstract] [Full Text] [Related]
23. [Leukotriene modifiers in the treatment of asthma].
Alvarez J
Rev Alerg Mex; 1999; 46(3):72-7. PubMed ID: 10425884
[TBL] [Abstract][Full Text] [Related]
24. Antileukotrienes in asthma: present situation.
García-Marcos L; Schuster A
Expert Opin Pharmacother; 2001 Mar; 2(3):441-66. PubMed ID: 11336598
[TBL] [Abstract][Full Text] [Related]
25. New approaches to anti-inflammatory therapy for asthma.
Wenzel SE
Am J Med; 1998 Mar; 104(3):287-300. PubMed ID: 9552092
[TBL] [Abstract][Full Text] [Related]
26. Leukotriene inhibitors and non-steroidal therapies in the treatment of asthma.
Krawiec ME; Wenzel SE
Expert Opin Pharmacother; 2001 Jan; 2(1):47-65. PubMed ID: 11336568
[TBL] [Abstract][Full Text] [Related]
27. [The role of leukotrienes in inflammation and leukotriene inhibitors].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 1999 Sep; 7(39):85-93. PubMed ID: 10598480
[TBL] [Abstract][Full Text] [Related]
28. The role of antileukotrienes in asthma management.
Tan RA
Curr Opin Pulm Med; 1998 Jan; 4(1):25-30. PubMed ID: 9526901
[TBL] [Abstract][Full Text] [Related]
29. New treatments for asthma: the role of leukotriene modifier agents.
Valacer DJ
J Natl Med Assoc; 1999 Aug; 91(8 Suppl):26S-39S. PubMed ID: 12653390
[TBL] [Abstract][Full Text] [Related]
30. New directions in asthma drug therapy.
Drazen JM
Hosp Pract (1995); 1998 Feb; 33(2):25-6, 31-3, 36-8. PubMed ID: 9484293
[TBL] [Abstract][Full Text] [Related]
31. Leukotriene modifiers. Expanded role may be on horizon.
Hayden ML
Adv Nurse Pract; 2000 Oct; 8(10):42-6. PubMed ID: 11761536
[No Abstract] [Full Text] [Related]
32. [New developments in asthma therapy: how do individual leukotriene antagonists work?].
Wagener M
Praxis (Bern 1994); 1998 Feb; 87(8):271-5. PubMed ID: 9542455
[TBL] [Abstract][Full Text] [Related]
33. [Leukotriene modifiers].
Minoguchi K; Adachi M
Nihon Rinsho; 2001 Oct; 59(10):1979-85. PubMed ID: 11676142
[TBL] [Abstract][Full Text] [Related]
34. A risk-benefit assessment of antileukotrienes in asthma.
Smith LJ
Drug Saf; 1998 Sep; 19(3):205-18. PubMed ID: 9747667
[TBL] [Abstract][Full Text] [Related]
35. Clinical pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors.
Drazen J
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S233-7; discussion S247-8. PubMed ID: 9647605
[TBL] [Abstract][Full Text] [Related]
36. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
Fal AM; Kopeć A
Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
[TBL] [Abstract][Full Text] [Related]
37. Antileukotriene therapy for asthma.
Larsen JS; Jackson SK
Am J Health Syst Pharm; 1996 Dec; 53(23):2821-30; quiz 2877-8. PubMed ID: 8957342
[TBL] [Abstract][Full Text] [Related]
38. Leukotriene synthesis inhibitors versus antagonists: the pros and cons.
Steinke JW; Culp JA
Curr Allergy Asthma Rep; 2007 May; 7(2):126-33. PubMed ID: 17437683
[TBL] [Abstract][Full Text] [Related]
39. Leukotrienes, antileukotrienes and asthma.
Montuschi P
Mini Rev Med Chem; 2008 Jun; 8(7):647-56. PubMed ID: 18537720
[TBL] [Abstract][Full Text] [Related]
40. Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma.
Drazen JM
Pharmacotherapy; 1997; 17(1 Pt 2):22S-30S. PubMed ID: 9017785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
